Literature DB >> 19945663

[Characteristics of prostate cancer in men less than 50-year-old].

M Peyromaure1, A Valéri, X Rebillard, P Beuzeboc, P Richaud, M Soulié, L Salomon.   

Abstract

OBJECTIVE: To report the characteristics of prostate cancer (PCa) in men less than 50-year-old and the results of different treatments of PCa in this population.
METHOD: A bibliographic research was performed using Pubmed database. The keywords that we used were: prostate cancer, age, young, radical prostatectomy, brachytherapy, radiotherapy, active surveillance. The studies which included a significant number of patients were selected. A total of 38 articles were used as bibliographic references.
RESULTS: PCa in young men does not seem to have different characteristics than in older men. Nevertheless, young men seem to have a lower risk of severe urinary and sexual sequelae, particularly following radical prostatectomy.
CONCLUSIONS: There is no recommendation regarding management of PCa in men less than 50-year-old. In case of localized cancer, two options may be considered. First option consists in decreasing the urinary and sexual complications of radical prostatectomy. A minimally-invasive treatment, such as brachytherapy or even active surveillance, may reach this objective. Second option consists in being more aggressive. To propose a radical prostatectomy offers to the patient the possibility of salvage radiation therapy in case of locally-advanced tumor or local recurrence.

Entities:  

Mesh:

Year:  2009        PMID: 19945663     DOI: 10.1016/j.purol.2009.04.010

Source DB:  PubMed          Journal:  Prog Urol        ISSN: 1166-7087            Impact factor:   0.915


  6 in total

1.  Prostate cancer in men aged less than 50 years at diagnosis.

Authors:  N J Kinnear; G Kichenadasse; S Plagakis; M E O'Callaghan; T Kopsaftis; S Walsh; D Foreman
Journal:  World J Urol       Date:  2016-04-12       Impact factor: 4.226

2.  Tectonic‑1 contributes to the growth and migration of prostate cancer cells in vitro.

Authors:  Zhijun Wang; Yi Gao; Yushan Liu; Jie Chen; Junkai Wang; Sishun Gan; Danfeng Xu; Xingang Cui
Journal:  Int J Mol Med       Date:  2015-08-14       Impact factor: 4.101

3.  Oxibendazole inhibits prostate cancer cell growth.

Authors:  Qiaoli Chen; Yuhua Li; Xiaoyu Zhou; Runsheng Li
Journal:  Oncol Lett       Date:  2017-12-11       Impact factor: 2.967

4.  Clinicopathological study of 9 cases of prostate cancer involving the rectal wall.

Authors:  Tao Tang; Zhengduo Yang; Dan Zhang; Jie Qu; Guang Liu; Shiwu Zhang
Journal:  Diagn Pathol       Date:  2017-01-17       Impact factor: 2.644

5.  Sepia ink oligopeptide induces apoptosis in prostate cancer cell lines via caspase-3 activation and elevation of Bax/Bcl-2 ratio.

Authors:  Fangfang Huang; Zuisu Yang; Di Yu; Jiabin Wang; Rong Li; Guofang Ding
Journal:  Mar Drugs       Date:  2012-09-27       Impact factor: 6.085

6.  Isolation and purification of a peptide from Bullacta exarata and its impaction of apoptosis on prostate cancer cell.

Authors:  Jianyin Ma; Fangfang Huang; Huanle Lin; Xian Wang
Journal:  Mar Drugs       Date:  2013-01-23       Impact factor: 5.118

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.